Evogene : First Quarter 2023 Financial Results Release & Con

developing and advancing novel microbiome- based therapeutics to treat human disorders powered by MicroBoost AI;


Lavie Bio Ltd. - developing and commercially advancing,... | May 4, 2023

Related Keywords

Israel , Rehovot , Hamerkaz , United States , , Evogene Ltd , Nasdaq , Evogene Schedules First Quarter , Results Release , Evogene Ltd Stock Exchange , News , Information , Press Release , Developing , End , Dvancing , Novel , Ased , Herapeutics , O , Treat , Human , Disorders , Owered , Y , Icroboost , Davie , Ohio , Ommercially Evgn Il0011050551 ,